[HTML][HTML] Subthalamic and pallidal deep brain stimulation for Parkinson's disease—meta-analysis of outcomes
…, JA Schlaeppi, A Nowacki, H You, JP Michelis… - NPJ Parkinson's …, 2021 - nature.com
Although deep brain stimulation (DBS) of the globus pallidus internus (GPi) and the subthalamic
nucleus (STN) has become an established treatment for Parkinson’s disease (PD), a …
nucleus (STN) has become an established treatment for Parkinson’s disease (PD), a …
[HTML][HTML] Combining multimodal biomarkers to guide deep brain stimulation programming in Parkinson disease
…, A Pogosyan, ML Lachenmayer, J Michelis… - … : technology at the …, 2023 - Elsevier
Background Deep brain stimulation (DBS) programming of multicontact DBS leads relies on
a very time-consuming manual screening procedure, and strategies to speed up this …
a very time-consuming manual screening procedure, and strategies to speed up this …
[HTML][HTML] Measuring compounds in exhaled air to detect Alzheimer's disease and Parkinson's disease
Background Alzheimer’s disease (AD) is diagnosed based upon medical history, neuropsychiatric
examination, cerebrospinal fluid analysis, extensive laboratory analyses and cerebral …
examination, cerebrospinal fluid analysis, extensive laboratory analyses and cerebral …
Deep brain stimulation: when to test directional?
…, G Tinkhauser, JP Michelis… - Movement disorders …, 2023 - Wiley Online Library
Background Directional deep brain stimulation (DBS) allows for steering of the stimulation
field, but extensive and time‐consuming testing of all segmented contacts is necessary to …
field, but extensive and time‐consuming testing of all segmented contacts is necessary to …
Stimulation of the globus pallidus internus in the treatment of Parkinson's disease: Long-term results of a monocentric cohort
…, K Petermann, I Debove, J Muellner, JP Michelis… - Parkinsonism & related …, 2019 - Elsevier
Background Pallidal deep brain stimulation (DBS) has shown to be beneficial in patients
with advanced levodopa-responsive Parkinson's disease (PD) in several short-term studies. …
with advanced levodopa-responsive Parkinson's disease (PD) in several short-term studies. …
Depression in blepharospasm: a question of facial feedback?
JR Bedarf, S Kebir, JP Michelis… - … disease and treatment, 2017 - Taylor & Francis
Depression is the most important nonmotor symptom in blepharospasm (BL). As facial
expression influences emotional perception, summarized as the facial feedback hypothesis, we …
expression influences emotional perception, summarized as the facial feedback hypothesis, we …
Long-term outcome and neuroimaging of deep brain stimulation in holmes tremor: a case series
…, A Nowacki, I Debove, J Muellner, JP Michelis… - … : Technology at the …, 2021 - Elsevier
Background Different deep brain stimulation (DBS) targets have been suggested as treatment
for patients with pharmacologically refractory Holmes tremor (HT). We report the clinical …
for patients with pharmacologically refractory Holmes tremor (HT). We report the clinical …
A single-nucleotide polymorphism of the osteopontin gene may contribute to a susceptibility to Lewy body disease
W Maetzler, J Michelis, J Tomiuk, A Melms… - Journal of neural …, 2009 - Springer
In Lewy body disease, inflammation is discussed to be involved in the pathophysiological
cascade. Osteopontin (OPN) is a multifunctional molecule, which is increased in inflammatory …
cascade. Osteopontin (OPN) is a multifunctional molecule, which is increased in inflammatory …
[HTML][HTML] Structure-function relationship of the posterior subthalamic area with directional deep brain stimulation for essential tremor
…, G Tinkhauser, K Petermann, AS Amil, J Michelis… - NeuroImage: Clinical, 2020 - Elsevier
Deep Brain Stimulation of the posterior subthalamic area is an emergent target for the
treatment of Essential Tremor. Due to the heterogeneous and complex anatomy of the posterior …
treatment of Essential Tremor. Due to the heterogeneous and complex anatomy of the posterior …
No differences of butyrylcholinesterase protein activity and allele frequency in Lewy body diseases
W Maetzler, S Keller, J Michelis, N Koehler… - Neurobiology of …, 2009 - Elsevier
Butyrylcholinesterase (BChE) genotypes and protein (BuChE) activity, especially in combination
with Apolipoprotein E4 (ApoE4), have been investigated as risk factors for developing …
with Apolipoprotein E4 (ApoE4), have been investigated as risk factors for developing …